These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22045968)

  • 1. Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial.
    Mancini GB; Hartigan PM; Bates ER; Sedlis SP; Maron DJ; Spertus JA; Berman DS; Kostuk WJ; Shaw LJ; Weintraub WS; Teo KK; Dada M; Chaitman BR; O'Rourke RA; Boden WE;
    Circ Cardiovasc Interv; 2011 Dec; 4(6):545-52. PubMed ID: 22045968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention.
    Glaser R; Selzer F; Faxon DP; Laskey WK; Cohen HA; Slater J; Detre KM; Wilensky RL
    Circulation; 2005 Jan; 111(2):143-9. PubMed ID: 15623544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
    Rosner GF; Kirtane AJ; Genereux P; Lansky AJ; Cristea E; Gersh BJ; Weisz G; Parise H; Fahy M; Mehran R; Stone GW
    Circulation; 2012 May; 125(21):2613-20. PubMed ID: 22550156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.
    Mancini GB; Hartigan PM; Bates ER; Chaitman BR; Sedlis SP; Maron DJ; Kostuk WJ; Spertus JA; Teo KK; Dada M; Knudtson M; Berman DS; Booth DC; Boden WE; Weintraub WS
    Am Heart J; 2013 Sep; 166(3):481-7. PubMed ID: 24016497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
    Mancini GBJ; Hartigan PM; Shaw LJ; Berman DS; Hayes SW; Bates ER; Maron DJ; Teo K; Sedlis SP; Chaitman BR; Weintraub WS; Spertus JA; Kostuk WJ; Dada M; Booth DC; Boden WE
    JACC Cardiovasc Interv; 2014 Feb; 7(2):195-201. PubMed ID: 24440015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).
    Goto K; Lansky AJ; Ng VG; Pietras C; Nargileci E; Mehran R; Parise H; Feit F; Ohman EM; White HD; Bertrand ME; Desmet W; Hamon M; Stone GW
    Am J Cardiol; 2014 Dec; 114(11):1638-45. PubMed ID: 25312637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).
    Padala SK; Sidhu MS; Hartigan PM; Maron DJ; Teo KK; Spertus JA; Mancini GB; Sedlis SP; Chaitman BR; Heller GV; Weintraub WS; Boden WE
    Am J Cardiol; 2015 Nov; 116(10):1509-15. PubMed ID: 26410604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
    Mancini GB; Bates ER; Maron DJ; Hartigan P; Dada M; Gosselin G; Kostuk W; Sedlis SP; Shaw LJ; Berman DS; Berger PB; Spertus J; Mavromatis K; Knudtson M; Chaitman BR; O'Rourke RA; Weintraub WS; Teo K; Boden WE;
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):320-7. PubMed ID: 20031857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression.
    Sanidas EA; Mintz GS; Maehara A; Cristea E; Wennerblom B; Iñiguez A; Fajadet J; Fahy M; Dressler O; Weisz G; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys P; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S95-S105. PubMed ID: 22421236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes.
    Brener SJ; Mintz GS; Cristea E; Weisz G; Maehara A; McPherson JA; Marso SP; Farhat N; Botker HE; Dressler O; Xu K; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S86-94. PubMed ID: 22421235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
    Marso SP; Mercado N; Maehara A; Weisz G; Mintz GS; McPherson J; Schiele F; Dudek D; Fahy M; Xu K; Lansky A; Templin B; Zhang Z; de Bruyne B; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S42-52. PubMed ID: 22421230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.
    Sardi GL; Laynez-Carnicero A; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2013 May; 81(6):949-56. PubMed ID: 22888029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.